StocksMedium•6 November 2026•
1 min read
FocalTherics Revenue Climbs 26% in Q3 Driven by U.S. Procedure Growth
Key Facts
1FocalTherics reported a 26% year-over-year revenue increase to $9.8 million for the third quarter.
2The company experienced a 32% growth in U.S. procedure volume during the reported period.
FocalTherics reported a 26% year-over-year revenue increase to $9.8 million for the third quarter of 2026. Benzinga reported that the growth was supported by a 32% surge in U.S. medical procedure volumes during the period.
The results highlight the company's operational expansion within the medical technology sector and its increasing market footprint. The financial data confirms a trend of double-digit growth in both core revenue and procedure frequency compared to the previous year.